Throughout our years of preparing and filing Food and Drug Administration (FDA) submissions, Premier Research has often encountered sponsors who cannot file a New Drug Application (NDA) or Biologic License Application (BLA) within expected time-frames, most commonly due to a failure to start and complete prerequisite activities before the targeted filing date. In this document, we will highlight those requirements that seem to be the most misunderstood.
Download the Guide
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.